Wealth Management Associates, Inc. Edwards Lifesciences Corp Transaction History

Wealth Management Associates, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 28, 2025	SELL	$69.28 - $93.38 $168,904 - $227,660	-2,438 Closed	0 $0
Q2 2023 May 28, 2025	SELL	$81.41 - $94.33 $11,478 - $13,300	-141 Reduced 5.47%	2,438 $230 Million
Q1 2023 May 28, 2025	BUY	$74.26 - $84.51 $191,516 - $217,951	2,579 New	2,579 $213 Million
Q4 2022 May 28, 2025	SELL	$68.3 - $87.44 $270,058 - $345,737	-3,954 Closed	0 $0
Q3 2022 May 28, 2025	BUY	$82.37 - $107.29 $66,637 - $86,797	809 Added 25.72%	3,954 $327 Million
Q2 2022 May 28, 2025	BUY	$86.5 - $128.27 $31,832 - $47,203	368 Added 13.25%	3,145 $299 Million
Q4 2021 May 28, 2025	SELL	$106.37 - $130.68 $71,267 - $87,555	-670 Reduced 19.44%	2,777 $360 Million
Q1 2021 May 28, 2025	BUY	$78.68 - $90.67 $37,294 - $42,977	474 Added 15.94%	3,447 $288 Million
Q2 2020 May 28, 2025	BUY	$57.54 - $76.95 $171,066 - $228,772	2,973 New	2,973 $205 Million
Q1 2020 May 28, 2025	SELL	$52.41 - $81.0 $51,938 - $80,271	-991 Closed	0 $0
Q3 2019 May 28, 2025	BUY	$61.55 - $75.43 $60,996 - $74,751	991 New	991 $218 Million

1,378

487M

2.77M

2.05M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $48.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Wealth Management Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Wealth Management Associates, Inc. with notifications on news.